Raymond James & Associates’s DTF Tax-Free Income 2028 Term Fund DTF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-12,997
| Closed | -$186K | – | 4155 |
|
|
2021
Q4 | $186K | Buy |
12,997
+1,496
| +13% | +$21.4K | ﹤0.01% | 3720 |
|
|
2021
Q3 | $166K | Buy |
11,501
+14
| +0.1% | +$208 | ﹤0.01% | 3711 |
|
|
2021
Q2 | $172K | Buy |
11,487
+14
| +0.1% | +$207 | ﹤0.01% | 3726 |
|
|
2021
Q1 | $165K | Sell |
11,473
-1,642
| -13% | -$23.7K | ﹤0.01% | 3665 |
|
|
2020
Q4 | $195K | Sell |
13,115
-9,964
| -43% | -$145K | ﹤0.01% | 3410 |
|
|
2020
Q3 | $333K | Sell |
23,079
-71,334
| -76% | -$1.03M | ﹤0.01% | 2887 |
|
|
2020
Q2 | $1.34M | Buy |
94,413
+4,653
| +5% | +$64.5K | ﹤0.01% | 1961 |
|
|
2020
Q1 | $1.25M | Sell |
89,760
-3,844
| -4% | -$56.5K | ﹤0.01% | 1842 |
|
|
2019
Q4 | $1.39M | Sell |
93,604
-739
| -0.8% | -$10.7K | ﹤0.01% | 2066 |
|
|
2019
Q3 | $1.36M | Buy |
94,343
+59,627
| +172% | +$837K | ﹤0.01% | 1997 |
|
|
2019
Q2 | $480K | Sell |
34,716
-7,866
| -18% | -$108K | ﹤0.01% | 2703 |
|
|
2019
Q1 | $563K | Sell |
42,582
-728
| -2% | -$9.51K | ﹤0.01% | 2574 |
|
|
2018
Q4 | $536K | Buy |
43,310
+4,418
| +11% | +$55.4K | ﹤0.01% | 2510 |
|
|
2018
Q3 | $500K | Buy |
38,892
+1,865
| +5% | +$24.5K | ﹤0.01% | 2705 |
|
|
2018
Q2 | $494K | Buy |
37,027
+23,192
| +168% | +$306K | ﹤0.01% | 2705 |
|
|
2018
Q1 | $184K | Sell |
13,835
-8,573
| -38% | -$116K | ﹤0.01% | 3158 |
|
|
2017
Q4 | $315K | Sell |
22,408
-3,364
| -13% | -$47.8K | ﹤0.01% | 2805 |
|
|
2017
Q3 | $368K | Sell |
25,772
-16,670
| -39% | -$243K | ﹤0.01% | 2656 |
|
|
2017
Q2 | $620K | Sell |
42,442
-39,764
| -48% | -$594K | ﹤0.01% | 2292 |
|
|
2017
Q1 | $1.22M | Buy |
82,206
+275
| +0.3% | +$4.14K | ﹤0.01% | 1845 |
|
|
2016
Q4 | $1.18M | Buy |
81,931
+734
| +0.9% | +$11K | ﹤0.01% | 1832 |
|
|
2016
Q3 | $1.32M | Buy |
81,197
+2,513
| +3% | +$41.4K | ﹤0.01% | 1705 |
|
|
2016
Q2 | $1.32M | Buy |
78,684
+8,298
| +12% | +$137K | ﹤0.01% | 1577 |
|
|
2016
Q1 | $1.11M | Buy |
70,386
+13,999
| +25% | +$214K | ﹤0.01% | 1624 |
|
|
2015
Q4 | $852K | Buy |
56,387
+711
| +1% | +$10.6K | ﹤0.01% | 1718 |
|
|
2015
Q3 | $813K | Buy |
55,676
+4,050
| +8% | +$59.2K | ﹤0.01% | 1697 |
|
|
2015
Q2 | $739K | Sell |
51,626
-3,014
| -6% | -$44.7K | ﹤0.01% | 1872 |
|
|
2015
Q1 | $834K | Buy |
54,640
+7,330
| +15% | +$114K | ﹤0.01% | 1767 |
|
|
2014
Q4 | $728K | Buy |
47,310
+361
| +0.8% | +$5.47K | ﹤0.01% | 1747 |
|
|
2014
Q3 | $706K | Buy |
46,949
+1,037
| +2% | +$16.2K | ﹤0.01% | 1700 |
|
|
2014
Q2 | $748K | Sell |
45,912
-1,091
| -2% | -$17K | ﹤0.01% | 1670 |
|
|
2014
Q1 | $695K | Buy |
47,003
+16,864
| +56% | +$245K | ﹤0.01% | 1620 |
|
|
2013
Q4 | $423K | Buy |
30,139
+8,239
| +38% | +$115K | ﹤0.01% | 1740 |
|
|
2013
Q3 | $313K | Buy |
21,900
+5,493
| +33% | +$77.6K | ﹤0.01% | 1773 |
|
|
2013
Q2 | $248K | Buy |
+16,407
| New | +$267K | ﹤0.01% | 1785 |
|
Other funds holding DTF
KIM
1CP
RCM
SIA
RCM
EVM
COLIM
MC
Raymond James & Associates's DTF Position: Q1 2022 in Review
Raymond James & Associates sold out of DTF Tax-Free Income 2028 Term Fund (DTF) in Q1 2022, closing a stake of 12,997 shares — an estimated $186K sold.
Raymond James & Associates first reported a position in DTF in Q2 2013 and held it in 35 quarters. The position peaked at $1.39M in Q4 2019. 30 funds tracked by Wall St. Rank hold DTF as of Q1 2022.
- Raymond James & Associates reported no remaining DTF Tax-Free Income 2028 Term Fund position as of Q1 2022 after selling out during the quarter.
- Raymond James & Associates sold 12,997 DTF Tax-Free Income 2028 Term Fund shares in Q1 2022, an estimated $186K.
- Raymond James & Associates first reported a position in DTF Tax-Free Income 2028 Term Fund in Q2 2013 and held it in 35 quarters.
- Raymond James & Associates's DTF Tax-Free Income 2028 Term Fund position peaked at $1.39M in Q4 2019.
- 30 funds tracked by Wall St. Rank held DTF Tax-Free Income 2028 Term Fund as of Q1 2022.
Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.